USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: T & B BIOCLONE, INC.
City: EDEN
State: NY
Zip+4: 14057
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (716) 845-3560

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $543,406.00 6
SBIR Phase II $500,000.00 1

Award List:

MONOCLONAL ANTIBODY (MOAB) CONJUGATES FOR THERAPY AND DIAGNO

Award Year / Program / Phase: 1985 / SBIR / Phase I
Agency: HHS
Principal Investigator: Shengchang Luo , Principal Investigator
Award Amount: $50,000.00

MONOCLONAL ANTIBODY (MOAB) CONJUGATES FOR THERAPY AND DIAGNO

Award Year / Program / Phase: 1988 / SBIR / Phase II
Agency: HHS
Principal Investigator: Shengchang Luo , Principal Investigator
Award Amount: $500,000.00
Abstract:
Monoclonal antibodies specific for a human lung tumor-associated glycoprotein antigen (gp-160) will be used to develop and test a cytotoxic prognostic immunoassays. the gp-160 is a membrane-associated glycoprotein that is found in significant levels on several major types of human lung tumors… More

CELL SEPARATION BY IMMUNOFLOTATION

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
A new concept for the separation of cells will be developed and evaluated. the basis of this separation technique, called immunoflotation, is a solid matrix that floats in water, making it possible to separate bound cells from unbound cells without centrifugation. either antigen or antibody is… More

HUMAN MONOCLONAL ANTIBODIES PRODUCED IN SCID MICE

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: HHS
Principal Investigator: Raymond J Kelleher
Award Amount: $50,000.00
Abstract:
A novel approach to the generation of human monoclonal antibodies will be investigated. c.b-17 scid/scid (scid) mice will be engrafted with human peripheral blood lymphocytes (pbl). these animals will be immunized with a variety of antigens to provoke an immune response by the human pbl. antigens to… More

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nejat K. Egilmez
Award Amount: $194,000.00

BIODEGRADABLE MICROSPHERES FOR CANCER IMMUNOTHERAPY

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nejat K. Egilmez
Award Amount: $99,906.00
Abstract:
DESCRIPTION: A novel technology for the local and sustained delivery of immunostimulatory molecules to the tumor environment for cancer immunotherapy is evaluated. The ability of biodegradable polymer micro spheres loaded with murine Interleukin- 12 to promote the… More

Interleukin10 Microsphere in Inflammatory Bowel Disease

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Nejat K. Egilmez
Award Amount: $99,500.00
Abstract:
The cytokine Interleukin-10 (IL-10) has shown promise in clinical trials for the treatment of inflammatory bowel disease (IBD). Currently IL-10 is administered to IBD patients systemically either by bolus intravenous or subcutaneous injections. Due to the short in vivo half-life of IL-10, repeated… More